Improvement of Risk Assessment in Cutaneous Melanoma (CM) by a Prognostic 31-Gene Expression Profile (31-GEP) Test over AJCC-Based Staging Alone. J of Skin 2018, 2, S70. https://doi.org/10.25251/skin.2.supp.70.